Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
OPTN | US
-0.05
-6.40%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
19/09/2024
0.80
0.85
0.86
0.79
OptiNose Inc. a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear nose throat and allergy specialists in the United States. The company offers XHANCE a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail a powder EDS device. OptiNose Inc. has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Orexia Therapeutics to develop manufacture import and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment diagnosis or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. The company was founded in 2000 and is headquartered in Yardley Pennsylvania.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
33.9%1 month
52.5%3 months
59.9%6 months
76.0%-
-
24.26
-2.94
0.96
-4.33
2.28
-
-18.45M
119.96M
119.96M
-
-31.96
-
5.30
-1.05K
14.05
5.91
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.25
Range1M
0.30
Range3M
0.51
Rel. volume
4.57
Price X volume
1.44M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Zomedica Pharmaceuticals Corp | ZOM | Drug Manufacturers-Specialty & Generic | 0.13 | 129.73M | 1.96% | n/a | 1.10% |
Assertio Therapeutics Inc | ASRT | Drug Manufacturers-Specialty & Generic | 1.35 | 128.70M | 3.85% | n/a | 30.76% |
Aceto Corporation | ACET | Drug Manufacturers-Specialty & Generic | 1.52 | 125.25M | 4.11% | n/a | 8.14% |
Veru Inc | VERU | Drug Manufacturers-Specialty & Generic | 0.8012 | 117.28M | 4.05% | n/a | 36.36% |
Relmada Therapeutics Inc | RLMD | Drug Manufacturers-Specialty & Generic | 3.5 | 105.61M | 0.29% | n/a | 0.00% |
Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 0.7391 | 92.15M | 0.35% | n/a | -148.05% |
Benitec Biopharma Limited | BNTC | Drug Manufacturers-Specialty & Generic | 8.625 | 86.99M | 3.17% | n/a | 3.08% |
INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 1.86 | 85.12M | 0.00% | n/a | 41.98% |
Silver Spike Investment Corp. Common Stock | SSIC | Drug Manufacturers-Specialty & Generic | 11.6 | 72.09M | 0.96% | 12.64 | 0.00% |
SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.63 | 61.71M | 3.82% | n/a | 25.73% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 37.9 | 107.64M | -1.76% | 5.90 | 15.58% |
Culp Inc | CULP | Textile Manufacturing | 6.35 | 79.31M | 5.31% | n/a | 11.29% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 5.78 | 62.58M | -6.47% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.04 | 18.78M | 13.06% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.02 | 12.43M | -7.27% | n/a | 16.03% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.737 | 11.34M | 3.80% | n/a | 422.08% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6475 | 6.16M | -2.76% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.315 | 4.97M | -1.56% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.42 | 3.63M | 1.43% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.751 | 1.10M | 24.54% | n/a | 0.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -4.33 | 16.67 | Cheaper |
Ent. to Revenue | 2.28 | 309.37 | Cheaper |
PE Ratio | - | 29.14 | - |
Price to Book | 24.26 | 12.81 | Expensive |
Dividend Yield | - | 2.80 | - |
Std. Deviation (3M) | 59.87 | 75.12 | Lower Risk |
Debt to Equity | -2.94 | -0.93 | Cheaper |
Debt to Assets | 0.96 | 0.45 | Expensive |
Market Cap | 119.96M | 5.22B | Emerging |